Papers by Mona Hosny Abdelsalam
The Egyptian Journal of Hospital Medicine, 2017
Background: Bone profile parameters are affected by decreased estimated GFR within chronic kidney... more Background: Bone profile parameters are affected by decreased estimated GFR within chronic kidney disease stage 3. We aimed to investigate if bone profile parameters response to vitamin D3 supplementation , within this stage , became affected by the presence or absence of diabetic state. Materials and methods: 30 patients having chronic kidney disease (stage 3) were enrolled in the study. 19 patients constituted nondiabetic group I and 11 patients constituted diabetic group II. All of them have received vitamin D3 1000 IU daily for 3 months. For all patients the following measurements were performed before and after vitamin D3 use :CBC , ESR1 & ESR2 , blood urea , serum creatinine , estimated GFR , complete urine analysis , serum Na , protein / creatinine ratio , serum calcium , serum phosphorus , calciumphosphorus product , serum albumin , serum alkaline phosphatase , and intact serum parathyroid hormone. Results: Serum calcium levels have increased, while intact parathyroid hormone has decreased within both groups , with a more obvious response within the diabetic group. Serum alkaline phosphatase , serum phosphorus , and calciumphosphorus product did not show any significant change, they were within their level after vitamin d3 use .ESR 1 and ESR 2 levels were higher from the start of the study within the diabetic group. Their mean level values have significantly decreased in a highly significant way within this group. Kidney function parameters and proteinuria have been deteriorated within the two groups , being worse within the diabetic group. Conclusion: Vitamin D3 use within stage 3 chronic renal disease patients is effective for patients support against bone mineral disturbances occurring within this disease .
Mona Hosny Abdel Salam, 0
Background: Bone profile parameters are affected by decreased estimated GFR within chronic kidney... more Background: Bone profile parameters are affected by decreased estimated GFR within chronic kidney disease stage 3. We aimed to investigate if bone profile parameters response to vitamin D3 supplementation , within this stage , became affected by the presence or absence of diabetic state. Materials and methods: 30 patients having chronic kidney disease (stage 3) were enrolled in the study. 19 patients constituted nondiabetic group I and 11 patients constituted diabetic group II. All of them have received vitamin D3 1000 IU daily for 3 months. For all patients the following measurements were performed before and after vitamin D3 use :CBC , ESR1 & ESR2 , blood urea , serum creatinine , estimated GFR , complete urine analysis , serum Na , protein / creatinine ratio , serum calcium , serum phosphorus , calciumphosphorus product , serum albumin , serum alkaline phosphatase , and intact serum parathyroid hormone. Results: Serum calcium levels have increased, while intact parathyroid hormone has decreased within both groups , with a more obvious response within the diabetic group. Serum alkaline phosphatase , serum phosphorus , and calciumphosphorus product did not show any significant change, they were within their level after vitamin d3 use .ESR 1 and ESR 2 levels were higher from the start of the study within the diabetic group. Their mean level values have significantly decreased in a highly significant way within this group. Kidney function parameters and proteinuria have been deteriorated within the two groups , being worse within the diabetic group. Conclusion: Vitamin D3 use within stage 3 chronic renal disease patients is effective for patients support against bone mineral disturbances occurring within this disease .
Background: Bone profile parameters are affected by decreased estimated GFR within chronic kidney... more Background: Bone profile parameters are affected by decreased estimated GFR within chronic kidney disease stage 3. We aimed to investigate if bone profile parameters response to vitamin D3 supplementation , within this stage , became affected by the presence or absence of diabetic state. Materials and methods: 30 patients having chronic kidney disease (stage 3) were enrolled in the study. 19 patients constituted nondiabetic group I and 11 patients constituted diabetic group II. All of them have received vitamin D3 1000 IU daily for 3 months. For all patients the following measurements were performed before and after vitamin D3 use :CBC , ESR1 & ESR2 , blood urea , serum creatinine , estimated GFR , complete urine analysis , serum Na , protein / creatinine ratio , serum calcium , serum phosphorus , calciumphosphorus product , serum albumin , serum alkaline phosphatase , and intact serum parathyroid hormone. Results: Serum calcium levels have increased, while intact parathyroid hormone has decreased within both groups , with a more obvious response within the diabetic group. Serum alkaline phosphatase , serum phosphorus , and calciumphosphorus product did not show any significant change, they were within their level after vitamin d3 use .ESR 1 and ESR 2 levels were higher from the start of the study within the diabetic group. Their mean level values have significantly decreased in a highly significant way within this group. Kidney function parameters and proteinuria have been deteriorated within the two groups , being worse within the diabetic group. Conclusion: Vitamin D3 use within stage 3 chronic renal disease patients is effective for patients support against bone mineral disturbances occurring within this disease .
QJM: An International Journal of Medicine, 2021
Vascular access dysfunction in hemodialysis patients has been correlated to low serum vitamin D l... more Vascular access dysfunction in hemodialysis patients has been correlated to low serum vitamin D level in previous studies. Vitamin D deficiency and hepatitis C virus infection have been linked to endothelial cell dysfunction, promoting inflammatory cascade.30 negative - & 30 positive - hepatitis C virus patients on prevalent hemodialysis in Ain Shams University Hospitals, were enrolled in the study. All patients had access blood flow < 800 ml/min. For all patients we performed: complete physical examination, complete blood count, serum ferritin, ESR 1st and 2nd hours, CRP, blood urea, serum creatinine, serum albumin, total and direct bilirubin, alanine transferase, aspartate transferase, prothrombin time, International Normalized Ratio, serum calcium and phosphorus, and serum intact parathyroid hormone. Previous laboratory tests were performed using conventional methods within our hospitals laboratories. Serum vitamin Dlevel was measured by Enzyme Linked Immunosorbent Assay. Acce...
Endocrine Abstracts, 2017
Endocrine Abstracts, 2013
Endocrine Abstracts, 2013
Uploads
Papers by Mona Hosny Abdelsalam